Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 02/12 03:59:59 pm
83.23 USD   +4.42%
02/09 VERTEX PHARMACE : to Present at Upcoming Investor Conferences
02/08 VERTEX PHARMACE : FDA declines to approve Vertex's Kalydeco in peopl..
02/05 VERTEX PHARMACE : Receives Complete Response Letter from U.S. FDA fo..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/08/2016 02/09/2016 02/10/2016 02/11/2016 02/12/2016 Date
82(c) 80.14(c) 81.73(c) 79.71(c) 83.23(c) Last
4 215 071 4 159 543 4 115 279 3 894 627 2 748 923 Volume
-5.32% -2.27% +1.98% -2.47% +4.42% Change
More quotes
Financials ($)
Sales 2016 2 103 M
EBIT 2016 606 M
Net income 2016 356 M
Finance 2016 646 M
Yield 2016 -
Sales 2017 3 130 M
EBIT 2017 1 540 M
Net income 2017 1 064 M
Finance 2017 2 147 M
Yield 2017 -
P/E ratio 2016 70,59
P/E ratio 2017 19,37
EV / Sales 2016 9,01x
EV / Sales 2017 5,57x
Capitalization 19 586 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
Sector
Biotechnology & Medical Research
Calendar
02/11 | 11:10amPresentation
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
02/11 VERTEX PHARMACEUTICALS : Patent Issued for Automated Developer for Immuno-Staine..
02/11 VERTEX PHARMACEUTICALS : Report Summarizes Rifampin Therapy Study Findings from ..
02/09 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/08 VERTEX PHARMACEUTICALS : FDA declines to approve Vertex's Kalydeco in people wit..
02/05 VERTEX PHARMACEUTICALS : Receives Complete Response Letter from U.S. FDA for Use..
02/04 VERTEX PHARMACEUTICALS : Health Canada Approves PrORKAMBI® lumacaftor/ivacaftor ..
02/04 VERTEX PHARMACEUTICALS : Findings from Vertex Pharmaceuticals Inc. Reveals New F..
01/28DJU.S. HOT STOCKS : Hot Stocks to Watch
More news
Sector news : Bio Therapeutic Drugs
08:52a AMGEN : Kyprolis launches in the UK for relapsed multiple myeloma
02/11 LONZA : Education Great Bay, UNH Manchester offer biotech program Department of ..
02/11 FDA panel recommends approval for copy of arthritis drug Remicade
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
07:38a Healthcare ratings roundup
02/10 MASSACHUSETTS-BASED PROTEOSTATIS THE : Early Stage And Stiff Competition Keeps U..
02/08 Vertex Pharmaceuticals Has Great Upside Potential
02/06 INSIDERINSIGHTS.COM DAILY ROUND UP 2 : Cit, rit, tgi, bcrx
02/05 FDA rejects Vertex's application for expanded use of KALYDECO


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions